Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
HIV incidence is falling in English gay men, say Public Health England

While several recent reports have shown that new HIV diagnoses have been falling in UK gay men, what really matters is the actual number of new HIV

Published
15 November 2017
By
Roger Pebody
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid US outbreaks

Since March, the CDC’s Division of Viral Hepatitis has identified hepatitis A outbreaks in several cities in California, Michigan and Utah, especially among people who are homeless and people who use drugs. Over the past six months, those ongoing outbreaks have resulted in supply stress for vaccine makers Merck and GSK, which sell U.S.-licensed hepatitis A shots Vaqta and Havrix, respectively.

Published
15 November 2017
From
FiercePharma
A reduction in new HIV diagnoses is no reason to reduce effort

The drop in new diagnoses among gay and bisexual men must be seen as an indicator of the reductions that are possible, rather than meaning that the job is done or that a downwards trajectory in new diagnoses will continue in the future. Importantly, so far these reductions have only been seen in one population group.

Published
15 November 2017
From
The King's Fund
Peter Sands Named Head of Global Disease-Fighting Agency

A former British banker was named executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday, taking over an international disease-fighting partnership that has struggled since its inception 15 years ago to raise enough money to fulfill its mission.

Published
15 November 2017
From
New York Times
Peter Sands is new Global Fund executive director

Peter Sands was announced as the new executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday. The news follows a chaotic few days during which Sands, the former CEO of Standard Chartered PLC, withdrew from the leadership race “for personal reasons” and then unexpectedly re-entered the race on Monday.

Published
15 November 2017
From
Devex
£600,000 funding of 12 projects by PHE to help prevent HIV

Public Health England (PHE) has announced the projects which have been awarded funding from the HIV Prevention Innovation Fund for 2017 to 2018. The projects have been chosen from across England to receive total funding of £600,000 from the Department of Health through PHE.

Published
14 November 2017
From
Public Health England
British Columbia just lost its last two excuses not to cover the pill that prevents HIV

Julio Montaner, the head of the BC Centre for Excellence in HIV/AIDS, told a room full of doctors and activists Nov 6, 2017, that his centre has negotiated a deal with generic drug manufacturers that could deliver the treatment without swelling the budget. “The message is, we’re ready,” Montaner told Xtra following his announcement. “It’s time to do this.”

Published
13 November 2017
From
XTRA, Vancouver
Up to a quarter of HIV-negative gay men attending three English clinics used PrEP in the last year

A prospective cohort study of gay men attending three clinics in southern England – 56 Dean Street and Mortimer Market Centre in London and the Brighton &

Published
13 November 2017
By
Gus Cairns
Danish court invalidates Gilead SPC

The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. On October 26, the court rejected Gilead’s motion for an injunction against generics maker Accord.

Published
10 November 2017
From
Life Sciences Intellectual Property Review
HIV in West and Central Africa – the state of an epidemic left behind

The UNAIDS, Médecins Sans Frontières (MSF) and African Union 18-month catch-up plan aims to increase treatment access and reduce mortality in West and Central Africa.

Published
10 November 2017
From
Avert

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.